Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: real-world outcomes in the United Kingdom
O'Reilly, M. A. Sanderson, R. Wilson, W. Burns, D. Besley, C. Creasey, T. Uttenthal, B. Elliot, Johnathon Roddie, C. Kuhnl, A.
O'Reilly, M. A.
Sanderson, R.
Wilson, W.
Burns, D.
Besley, C.
Creasey, T.
Uttenthal, B.
Elliot, Johnathon
Roddie, C.
Kuhnl, A.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
O'Reilly MA, Sanderson R, Wilson W, Burns D, Besley C, Creasey T, et al. Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom. Blood. 2022 Nov;140:7519-21. PubMed PMID: WOS:000893230300236.